Neuca S.A. Market Cap ($869.33 Million)
Market Cap & Net Worth: Neuca S.A. (NEU)
Neuca S.A. market cap. Neuca S.A. (WAR:NEU) has a market capitalization of $869.33 Million (zł3.16 Billion) as of November 1, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #9141 globally and #48 in its home market, demonstrating a -0.57% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Neuca S.A.'s stock price zł701.00 by its total outstanding shares 4506044 (4.51 Million). Also see NEU operating cash flow for how efficiently the company converts equity into cash flow.
Neuca S.A. Market Cap History (2015–2026)
Neuca S.A. market cap history from 2015 to 2026. Data shows growth from $380.40 Million to $869.33 Million (8.25% CAGR). Check NEU stock price and chart for real-time trading data and today's change.
Index Memberships
Neuca S.A. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
mWIG40
MWIG40
|
$75.09 Billion | 1.16% | #20 of 40 |
Weight: Neuca S.A.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Neuca S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Neuca S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Neuca S.A. net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.07x
Neuca S.A.'s market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.49x
Neuca S.A.'s market cap is 6.49 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $418.52 Million | $7.08 Billion | $111.73 Million | 0.06x | 3.75x |
| 2017 | $292.40 Million | $7.49 Billion | $94.50 Million | 0.04x | 3.09x |
| 2018 | $272.35 Million | $7.75 Billion | $98.27 Million | 0.04x | 2.77x |
| 2019 | $433.16 Million | $8.28 Billion | $117.66 Million | 0.05x | 3.68x |
| 2020 | $758.14 Million | $9.25 Billion | $141.79 Million | 0.08x | 5.35x |
| 2021 | $992.61 Million | $9.86 Billion | $150.66 Million | 0.10x | 6.59x |
| 2022 | $780.56 Million | $11.23 Billion | $137.24 Million | 0.07x | 5.69x |
| 2023 | $1.13 Billion | $11.81 Billion | $146.27 Million | 0.10x | 7.72x |
| 2024 | $1.08 Billion | $12.61 Billion | $154.24 Million | 0.09x | 7.02x |
| 2025 | $1.01 Billion | $13.64 Billion | $155.58 Million | 0.07x | 6.49x |
Competitor Companies of NEU by Market Capitalization
Companies near Neuca S.A. in the global market cap rankings as of November 1, 2026. Also see NEU total asset value for a full breakdown of the balance sheet.
Key companies related to Neuca S.A. by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #248 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #451 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #626 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1151 globally with a market cap of $22.30 Billion USD ( AU$31.51 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #248 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $994.58 |
| #451 | Cencora Inc. | NYSE:COR | $61.32 Billion | $330.84 |
| #626 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $250.48 |
| #1151 | Sigma Healthcare Ltd | AU:SIG | $22.30 Billion | AU$2.73 |
Market Capitalization of Neuca S.A. (2015–2026)
Market capitalization of Neuca S.A. from 2015 to today. Between 2015 and today, Neuca S.A.'s market cap moved from $380.40 Million to $ 869.33 Million, with a yearly change of 8.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł869.33 Million | -13.88% |
| 2025 | zł1.01 Billion | -6.76% |
| 2024 | zł1.08 Billion | -4.13% |
| 2023 | zł1.13 Billion | +44.67% |
| 2022 | zł780.56 Million | -21.36% |
| 2021 | zł992.61 Million | +30.93% |
| 2020 | zł758.14 Million | +75.03% |
| 2019 | zł433.16 Million | +59.04% |
| 2018 | zł272.35 Million | -6.85% |
| 2017 | zł292.40 Million | -30.14% |
| 2016 | zł418.52 Million | +10.02% |
| 2015 | zł380.40 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Neuca S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $869.33 Million USD |
| MoneyControl | $869.33 Million USD |
| MarketWatch | $869.33 Million USD |
| marketcap.company | $869.33 Million USD |
| Reuters | $869.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Neuca S.A.
NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic an… Read more